Last 12 months
Inside the activity.
0 purchase rows · 59 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 26 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 14 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2022 Filed Mar 11, 2022 21:17 UTC |
Neervannan SeshadriChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 69,498 | $0.00 Strike: $19.59 | $0.00 |
DisclosureSEC source: 0001827584-22-000002 · wf-form4_164703341053306.xml · derivative · entry 1 Neervannan Seshadri · CIK 0001827584 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,498 Underlying: Common Stock · 69,498 shares Expires 2032-03-08 F1 · derivative.exercise_date: 25% of the option shares shall vest on March 9, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:15 UTC |
Wahl BryanGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 34,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001841401-22-000002 · wf-form4_164703330355786.xml · derivative · entry 3 Wahl Bryan · CIK 0001841401 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,171 Underlying: Common Stock · 34,171 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: 30% of the RSUs will vest on November 29, 2022 and 70% of the RSUs will vest on November 29, 2023 subject to the Reporting Person's continuous service. F4 · derivative.expiration_date: 30% of the RSUs will vest on November 29, 2022 and 70% of the RSUs will vest on November 29, 2023 subject to the Reporting Person's continuous service. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:15 UTC |
Wahl BryanGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 19,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001841401-22-000002 · wf-form4_164703330355786.xml · derivative · entry 2 Wahl Bryan · CIK 0001841401 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,160 Underlying: Common Stock · 19,160 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service. F3 · derivative.expiration_date: 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:15 UTC |
Wahl BryanGeneral Counsel
|
GrantStock Option (right to buy) · Derivative | 65,312 | $0.00 Strike: $19.59 | $0.00 |
DisclosureSEC source: 0001841401-22-000002 · wf-form4_164703330355786.xml · derivative · entry 1 Wahl Bryan · CIK 0001841401 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,312 Underlying: Common Stock · 65,312 shares Expires 2032-03-08 F1 · derivative.exercise_date: 25% of the option shares shall vest on March 9, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:13 UTC |
Holdbrook Mark J.V.P., Clinical Affairs
|
GrantRestricted Stock Units · Derivative | 10,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001827564-22-000002 · wf-form4_164703319575280.xml · derivative · entry 2 Holdbrook Mark J. · CIK 0001827564 · V.P., Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,612 Underlying: Common Stock · 10,612 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service. F3 · derivative.expiration_date: 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:13 UTC |
Holdbrook Mark J.V.P., Clinical Affairs
|
GrantStock Option (right to buy) · Derivative | 36,173 | $0.00 Strike: $19.59 | $0.00 |
DisclosureSEC source: 0001827564-22-000002 · wf-form4_164703319575280.xml · derivative · entry 1 Holdbrook Mark J. · CIK 0001827564 · V.P., Clinical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,173 Underlying: Common Stock · 36,173 shares Expires 2032-03-08 F1 · derivative.exercise_date: 25% of the option shares shall vest on March 9, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:10 UTC |
Mottiwala AzizChief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 19,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001788542-22-000002 · wf-form4_164703293653715.xml · derivative · entry 2 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,160 Underlying: Common Stock · 19,160 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service. F3 · derivative.expiration_date: 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:10 UTC |
Mottiwala AzizChief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 65,312 | $0.00 Strike: $19.59 | $0.00 |
DisclosureSEC source: 0001788542-22-000002 · wf-form4_164703293653715.xml · derivative · entry 1 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,312 Underlying: Common Stock · 65,312 shares Expires 2032-03-08 F1 · derivative.exercise_date: 25% of the option shares shall vest on March 9, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:07 UTC |
Whitfield Dianne C.Chief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 34,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001839516-22-000002 · wf-form4_164703276995746.xml · derivative · entry 3 Whitfield Dianne C. · CIK 0001839516 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,171 Underlying: Common Stock · 34,171 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: 30% of the RSUs will vest on November 29, 2022 and 70% of the RSUs will vest on November 29, 2023, subject to the Reporting Person's continuous service. F4 · derivative.expiration_date: 30% of the RSUs will vest on November 29, 2022 and 70% of the RSUs will vest on November 29, 2023, subject to the Reporting Person's continuous service. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:07 UTC |
Whitfield Dianne C.Chief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 17,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001839516-22-000002 · wf-form4_164703276995746.xml · derivative · entry 2 Whitfield Dianne C. · CIK 0001839516 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,850 Underlying: Common Stock · 17,850 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service. F3 · derivative.expiration_date: 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:07 UTC |
Whitfield Dianne C.Chief Human Resources Officer
|
GrantStock Option (right to buy) · Derivative | 60,846 | $0.00 Strike: $19.59 | $0.00 |
DisclosureSEC source: 0001839516-22-000002 · wf-form4_164703276995746.xml · derivative · entry 1 Whitfield Dianne C. · CIK 0001839516 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,846 Underlying: Common Stock · 60,846 shares Expires 2032-03-08 F1 · derivative.exercise_date: 25% of the option shares shall vest on March 9, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:04 UTC |
Greenstein Leonard M.Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 17,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001519692-22-000002 · wf-form4_164703265817676.xml · derivative · entry 2 Greenstein Leonard M. · CIK 0001519692 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,850 Underlying: Common Stock · 17,850 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service. F3 · derivative.expiration_date: 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:04 UTC |
Greenstein Leonard M.Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 60,846 | $0.00 Strike: $19.59 | $0.00 |
DisclosureSEC source: 0001519692-22-000002 · wf-form4_164703265817676.xml · derivative · entry 1 Greenstein Leonard M. · CIK 0001519692 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,846 Underlying: Common Stock · 60,846 shares Expires 2032-03-08 F1 · derivative.exercise_date: 25% of the option shares shall vest on March 9, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 22:36 UTC |
Trevejo Jose M.CHIEF MEDICAL OFFICER
|
GrantRestricted Stock Units · Derivative | 30,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001661539-22-000005 · wf-form4_164392778280060.xml · derivative · entry 2 Trevejo Jose M. · CIK 0001661539 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,197 Underlying: Common Stock · 30,197 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service. F3 · derivative.expiration_date: 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 22:36 UTC |
Trevejo Jose M.CHIEF MEDICAL OFFICER
|
GrantEmployee Stock Option (right to buy) · Derivative | 116,424 | $0.00 Strike: $20.64 | $0.00 |
DisclosureSEC source: 0001661539-22-000005 · wf-form4_164392778280060.xml · derivative · entry 1 Trevejo Jose M. · CIK 0001661539 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,424 Underlying: Common Stock · 116,424 shares Expires 2032-01-31 F1 · derivative.exercise_date: 25% of the option shares shall vest on February 1, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service. Read SEC document |
| December 31, 2021 Filed Jan 5, 2022 02:10 UTC |
Lin Elizabeth YeuDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $22.50 | $0.00 |
DisclosureSEC source: 0001209191-22-001245 · doc4.xml · derivative · entry 1 Lin Elizabeth Yeu · CIK 0001842190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-12-31 F1 · derivative.exercise_date: The option shares vest in 3 annual installments beginning on December 31, 2022, subject to the Reporting Person's continuous service. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 23:56 UTC |
Ackermann MichaelDirector
|
SaleCommon Stock | 528 | $26.65 | $14,071.20 |
DisclosureSEC source: 0001819790-21-000059 · wf-form4_163857580594057.xml · nonDerivative · entry 4 Ackermann Michael · CIK 0001791249 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,204,016 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021. F5 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $26.53 to $27.02. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 23:56 UTC |
Ackermann MichaelDirector
|
SaleCommon Stock | 809 | $25.87 | $20,928.83 |
DisclosureSEC source: 0001819790-21-000059 · wf-form4_163857580594057.xml · nonDerivative · entry 3 Ackermann Michael · CIK 0001791249 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,204,544 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021. F4 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $25.51 to $26.30. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 23:56 UTC |
Ackermann MichaelDirector
|
SaleCommon Stock | 2,054 | $24.68 | $50,692.72 |
DisclosureSEC source: 0001819790-21-000059 · wf-form4_163857580594057.xml · nonDerivative · entry 2 Ackermann Michael · CIK 0001791249 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,205,353 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021. F3 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $24.28 to $25.16. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 23:56 UTC |
Ackermann MichaelDirector
|
SaleCommon Stock | 2,442 | $23.85 | $58,241.70 |
DisclosureSEC source: 0001819790-21-000059 · wf-form4_163857580594057.xml · nonDerivative · entry 1 Ackermann Michael · CIK 0001791249 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,207,407 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices with the range of $23.24 to $24.22. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 23:55 UTC |
Azamian Bobak R.Director · President and CEO
|
SaleCommon Stock | 578 | $26.76 | $15,467.28 |
DisclosureSEC source: 0001819790-21-000057 · wf-form4_163857571118270.xml · nonDerivative · entry 4 Azamian Bobak R. · CIK 0001827672 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,204,106 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021. F6 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $26.57 to $27.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 23:55 UTC |
Azamian Bobak R.Director · President and CEO
|
SaleCommon Stock | 760 | $25.90 | $19,684.00 |
DisclosureSEC source: 0001819790-21-000057 · wf-form4_163857571118270.xml · nonDerivative · entry 3 Azamian Bobak R. · CIK 0001827672 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,204,684 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021. F5 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $25.33 to $26.26. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 23:55 UTC |
Azamian Bobak R.Director · President and CEO
|
SaleCommon Stock | 2,101 | $24.70 | $51,894.70 |
DisclosureSEC source: 0001819790-21-000057 · wf-form4_163857571118270.xml · nonDerivative · entry 2 Azamian Bobak R. · CIK 0001827672 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,205,444 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021. F4 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $24.3 to $25.28. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 23:55 UTC |
Azamian Bobak R.Director · President and CEO
|
SaleCommon Stock | 2,394 | $23.86 | $57,120.84 |
DisclosureSEC source: 0001819790-21-000057 · wf-form4_163857571118270.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,207,545 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $23.28 to $24.22. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| November 11, 2021 Filed Nov 17, 2021 00:58 UTC |
LINK WILLIAM J PHDDirector
|
OtherCommon Stock | 4,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-064905 · doc4.xml · nonDerivative · entry 2 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Flying L Partners XI, LLC Disclosed balance after: 4,348 F3 · kind: Represents the receipt of shares from a pro-rata in-kind distribution and not a purchase or sale, without additional consideration by Flying L Investments XI, LLC to its partners. F4 · ownership.nature: The shares are held directly held by Flying L Partners XI, LLC. The Reporting Person is the manager of Flying L Partners XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein. Read SEC document |
| November 11, 2021 Filed Nov 17, 2021 00:58 UTC |
LINK WILLIAM J PHDDirector
|
OtherCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-064905 · doc4.xml · nonDerivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Flying L Investments XI, LLC Disclosed balance after: 862,301 F1 · kind: Represents an in-kind pro-rata distribution, and not a purchase or sale, without additional consideration by Flying L Investments XI, LLC to its partners pursuant to a 10b5-1 plan entered into by Flying L Investments XI, LLC. F2 · ownership.nature: The shares are held directly held by Flying L Investments XI, LLC. The Reporting Person is the manager of Flying L Investments XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 23:29 UTC |
Mottiwala AzizChief Commercial Officer
|
SaleCommon Stock | 1,889 | $28.11 | $53,099.79 |
DisclosureSEC source: 0001819790-21-000055 · wf-form4_163658697878613.xml · nonDerivative · entry 1 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,203 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2021. F2 · shares: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $28.00 to $28.56. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 22:49 UTC |
Mottiwala AzizChief Commercial Officer
|
SaleCommon Stock | 11 | $28.11 | $309.21 |
DisclosureSEC source: 0001819790-21-000047 · wf-form4_163641175289229.xml · nonDerivative · entry 2 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,092 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2021. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 22:49 UTC |
Mottiwala AzizChief Commercial Officer
|
SaleCommon Stock | 100 | $28.03 | $2,803.00 |
DisclosureSEC source: 0001819790-21-000047 · wf-form4_163641175289229.xml · nonDerivative · entry 1 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,103 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2021. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 23:03 UTC |
Mottiwala AzizChief Commercial Officer
|
SaleCommon Stock | 542 | $27.07 | $14,672.48 |
DisclosureSEC source: 0001819790-21-000045 · wf-form4_163606700536434.xml · nonDerivative · entry 2 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,203 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2021. F3 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $27.020 to $27.730. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 23:03 UTC |
Mottiwala AzizChief Commercial Officer
|
SaleCommon Stock | 5,458 | $26.75 | $146,017.87 |
DisclosureSEC source: 0001819790-21-000045 · wf-form4_163606700536434.xml · nonDerivative · entry 1 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,745 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2021. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $26.020 to $27.015. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 23:00 UTC |
Ackermann MichaelDirector
|
SaleCommon Stock | 869 | $28.18 | $24,488.42 |
DisclosureSEC source: 0001819790-21-000043 · wf-form4_163598040275686.xml · nonDerivative · entry 2 Ackermann Michael · CIK 0001791249 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,209,849 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021. F3 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $28.11 to $28.27. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 23:00 UTC |
Ackermann MichaelDirector
|
SaleCommon Stock | 4,964 | $27.76 | $137,800.64 |
DisclosureSEC source: 0001819790-21-000043 · wf-form4_163598040275686.xml · nonDerivative · entry 1 Ackermann Michael · CIK 0001791249 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,210,718 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices with the range of $27.10 to $28.07. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 22:55 UTC |
Azamian Bobak R.Director · President and CEO
|
SaleCommon Stock | 800 | $28.21 | $22,568.00 |
DisclosureSEC source: 0001819790-21-000041 · wf-form4_163598012144660.xml · nonDerivative · entry 2 Azamian Bobak R. · CIK 0001827672 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,209,939 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021. F4 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $28.10 to $28.27. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 22:55 UTC |
Azamian Bobak R.Director · President and CEO
|
SaleCommon Stock | 5,033 | $27.76 | $139,716.08 |
DisclosureSEC source: 0001819790-21-000041 · wf-form4_163598012144660.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,210,739 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $27.10 to $28.09. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 20:48 UTC |
Ackermann MichaelDirector
|
SaleCommon Stock | 4,517 | $26.45 | $119,474.65 |
DisclosureSEC source: 0001819790-21-000039 · wf-form4_163424449168205.xml · nonDerivative · entry 2 Ackermann Michael · CIK 0001791249 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,215,682 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021. F3 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $26.12 to $26.93. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 20:48 UTC |
Ackermann MichaelDirector
|
SaleCommon Stock | 1,116 | $25.56 | $28,524.96 |
DisclosureSEC source: 0001819790-21-000039 · wf-form4_163424449168205.xml · nonDerivative · entry 1 Ackermann Michael · CIK 0001791249 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,220,199 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices with the range of $25.08 to $26.02. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 20:44 UTC |
Azamian Bobak R.Director · President and CEO
|
SaleCommon Stock | 4,698 | $26.44 | $124,215.12 |
DisclosureSEC source: 0001819790-21-000037 · wf-form4_163424427780477.xml · nonDerivative · entry 2 Azamian Bobak R. · CIK 0001827672 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,215,772 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021. F4 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $26.05 to $26.76. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 20:44 UTC |
Azamian Bobak R.Director · President and CEO
|
SaleCommon Stock | 833 | $25.49 | $21,233.17 |
DisclosureSEC source: 0001819790-21-000037 · wf-form4_163424427780477.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,220,470 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $25.04 to $26.00. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| October 08, 2021 Filed Oct 12, 2021 22:47 UTC |
Ackermann MichaelDirector
|
SaleCommon Stock | 200 | $25.03 | $5,006.00 |
DisclosureSEC source: 0001819790-21-000035 · wf-form4_163407884464685.xml · nonDerivative · entry 1 Ackermann Michael · CIK 0001791249 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,221,315 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices with the range of $25.000 to $25.06, inclusive. The Reporting Person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 08, 2021 Filed Oct 12, 2021 22:43 UTC |
Azamian Bobak R.Director · President and CEO
|
SaleCommon Stock | 302 | $25.02 | $7,555.44 |
DisclosureSEC source: 0001819790-21-000033 · wf-form4_163407859702568.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,221,303 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $25.000 to $25.055. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 20:51 UTC |
Mottiwala AzizChief Commercial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,593 | $0.45 Strike: $0.45 | $1,166.85 |
DisclosureSEC source: 0001819790-21-000031 · wf-form4_163165264472878.xml · derivative · entry 5 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 772 Underlying: Common Stock · 2,593 shares Expires 2028-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option granted under the Plan. 25% of the option shares vested and became exercisable on July 27, 2019 and the remaining option shares vest and become exercisable in 36 equal monthly installments thereafter. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 20:51 UTC |
Mottiwala AzizChief Commercial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,350 | $10.99 Strike: $10.99 | $47,806.50 |
DisclosureSEC source: 0001819790-21-000031 · wf-form4_163165264472878.xml · derivative · entry 4 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,989 Underlying: Common Stock · 4,350 shares Expires 2030-09-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option granted under the Tarsus Pharmaceuticals, Inc. 2016 Stock Plan (the "Plan"). The option shares vest and become exercisable in 48 equal monthly installments beginning on October 25, 2020. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 20:51 UTC |
Mottiwala AzizChief Commercial Officer
|
SaleCommon Stock | 2,593 | $22.15 | $57,434.95 |
DisclosureSEC source: 0001819790-21-000031 · wf-form4_163165264472878.xml · nonDerivative · entry 3 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,203 F1 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $22.000 to $22.200. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 20:51 UTC |
Mottiwala AzizChief Commercial Officer
|
Exercise / conversionCommon Stock | 2,593 | $0.45 | $1,166.85 |
DisclosureSEC source: 0001819790-21-000031 · wf-form4_163165264472878.xml · nonDerivative · entry 2 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 20:51 UTC |
Mottiwala AzizChief Commercial Officer
|
Exercise / conversionCommon Stock | 4,350 | $10.99 | $47,806.50 |
DisclosureSEC source: 0001819790-21-000031 · wf-form4_163165264472878.xml · nonDerivative · entry 1 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 22:53 UTC |
Ackermann MichaelDirector
|
SaleCommon Stock | 5,833 | $25.24 | $147,236.59 |
DisclosureSEC source: 0001209191-21-054888 · doc4.xml · nonDerivative · entry 1 Ackermann Michael · CIK 0001791249 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,221,515 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices with the range of $25.000 to $25.970, inclusive. The Reporting Person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:51 UTC |
Azamian Bobak R.Director · President and CEO
|
SaleCommon Stock | 100 | $26.40 | $2,640.00 |
DisclosureSEC source: 0001827672-21-000002 · wf-form4_163070587277035.xml · nonDerivative · entry 2 Azamian Bobak R. · CIK 0001827672 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,221,605 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:51 UTC |
Azamian Bobak R.Director · President and CEO
|
SaleCommon Stock | 5,733 | $25.23 | $144,660.79 |
DisclosureSEC source: 0001827672-21-000002 · wf-form4_163070587277035.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 1,221,705 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $25.000 to $25.97. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| August 11, 2021 Filed Aug 12, 2021 23:28 UTC |
Crane Rosemary ADirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $25.05 | $0.00 |
DisclosureSEC source: 0001209191-21-051272 · doc4.xml · derivative · entry 1 Crane Rosemary A · CIK 0001443343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-08-11 F1 · derivative.exercise_date: The option shares vest in 3 annual installments beginning on August 11, 2022, subject to the Reporting Person's continuous service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.